Şunu aradınız:: as enteric coated pellets (İngilizce - İsveççe)

enteric coated tablet
enterotabletter

tablets, enteric coated
enterotabletter

didanosine (enteric coated
didanosin (enterokapslar)

enteric-coated didanosine, but
enterokapslar, men

enteric coated tablet dose form
enterotabletter

enteric coated tablet dosage form
enterotabletter

tablet, delayed release (enteric coated)
enterotabletter

esomeprazole is acid labile and is administered orally as enteric-coated granules.
esomeprazol är instabilt i sur miljö och administreras därför peroralt som magsaftresistenta granulat.

didanosine enteric-coated 400 mg sd (indinavir 800 mg sd)
didanosin enterodragerade

dosing of enteric-coated didanosine and aptivus soft capsules, co-
mjuka kapslar tillsammans med

lansoprazole is rapidly inactivated by gastric acid and consequently administered as enteric-coated granules in gelatin capsules.
lansoprazol inaktiveras snabbt av magsyra och administreras därför som enterodragerade granulat i gelatinkapslar.

lansoprazole is rapidly inactivated by gastric acid and lansoprazole is consequently administered as enteric coated granules in gelatin capsules.
lansoprazol inaktiveras snabbt av magsyra och administreras därför som enterodragerade granulat i gelatinkapslar.

if you are taking didanosine enteric coated tablets, it should be separated by at least two hours from aptivus.
om du använder didanosin enterotabletter, ska de tas med minst 2 timmars mellanrum från dosering av aptivus.

as lansoprazole is rapidly inactivated by gastric acid, it is administered orally in enteric-coated form(s) for systemic absorption.
eftersom lansoprazol snabbt inaktiveras av magsyra, sker oral administrering i enterodragerad form för att få systemisk absorption.

no significant effect on atazanavir concentrations was observed when administered with enteric-coated didanosine, but administration with food decreased didanosine concentrations.
ingen signifikant effekt på atazanavirkoncentrationen observerades vid samtidig administrering med didanosin enterokapslar, men administrering med föda minskade didanosinkoncentrationen.

didanosine (enteric coated capsules) 400 mg single dose (atazanavir 300 mg once daily with ritonavir 100 mg once daily)
didanosin (enterokapslar) 400 mg endos (atazanavir 300 mg qd med ritonavir 100 mg qd)

dosing of enteric-coated didanosine and aptivus soft capsules, co-administered with low dose ritonavir, should be separated by at least 2 hours to avoid formulation incompatibility.
dosering av didanosin med magsaftresistent hölje och aptivus mjuka kapslar tillsammans med lågdos ritonavir, ska ske med minst 2 timmars mellanrum för att undvika inkompatibilitet mellan beredningsformerna.

administration of 325 mg (or equivalent) non-enteric coated acetylsalicylic acid, 30 minutes prior to tecfidera, over 4 days of dosing, did not alter the pharmacokinetic profile of tecfidera and reduced the occurrence and severity of flushing in a healthy volunteer study.
administrering av 325 mg (eller motsvarande) acetylsalicylsyra utan enterobeläggning, 30 minuter före tecfidera, under 4 dagars dosering, förändrade inte den farmakokinetiska profilen för tecfidera och reducerade uppkomsten och svårighetsgraden av hudrodnad i en studie på friska frivilliga.

each capsule contains .
varje kapsel innehåller (vita till svagt bruna enterodragerade granulatkorn).